Biologics CDMO AsymBio to secure $184m from Asymchem Group, Hillhouse Qirui and other investors to support manufacturing growth
The funding, approximately 1.2397 billion yuan, will be used for AsymBio's principal business operations, further expansion of its manufacturing capacity, and scaling of client programs. Following the transaction, Asymchem Group's shareholding in its subsidiary AsymBio is set to rise to 83.4965%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Turkish investment bank Tera Group collapsed, with $14 billion in funds liquidated. The Department of Justice characterized it as a "Ponzi-like scheme."
-
2
"Crypto King" Barry Silbert is shifting DCG institutional capital towards AI token Bittensor (TAO), calling it the most exciting project since Bitcoin.
-
3
After the UK sanctioned HTX, TRON Inc. began receiving TRX through an intermediary wallet funded by HTX.
-
4
Nigerian Firms Seek Regulatory Approval to Attract African Investors for Dangote Refinery IPO
-
5
Allen Media Group CEO Byron Allen Emphasizes Deleveraging After Company Loans Hit Low
-
6
Radix blockchain suffers $1.3 million drain due to 3-year-old bug, forcing 10-day halt
-
7
Bitcoin hits $81K as US bond yields rebound on global oil woes
-
8
Musk Predicts: AI to Double US GDP Growth from ~2% to ~4% or Even Higher Next Year
-
9
AI data center company Nscale has publicly filed for a U.S. IPO, seeking to raise up to $3 billion. NVIDIA holds over 5% of its shares, and it has secured a $45 billion lease commitment from Anthropic.
-
10
90 million USDC (approximately $90 million) minted on-chain.
Markets Today
Recommended Reading


